{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:44:51Z","timestamp":1778575491010,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Group B Streptococcal (GBS) infections in the United States are a leading cause of meningitis and sepsis in newborns. The CDC therefore recommends GBS screening for all pregnant women at 35\u201337\u2009weeks of gestation and administration of intrapartum prophylaxis (in those that tested positive) as an effective means of controlling disease transmission. Several FDA approved molecular diagnostic tests are available for rapid and accurate detection of GBS in antepartum women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In this study, we report a clinical comparison of the Xpert GBS LB assay and a novel FDA-cleared test, Revogene GBS LB assay. A total of 250 vaginal-rectal swabs from women undergoing prenatal screening were submitted to the University of Wisconsin\u2019s clinical microbiology laboratory for GBS testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found 96.8% of samples were concordant between the two tests, while 3.2% were discordant with a positive percent agreement of 98.0% and a negative percent agreement of 96.5% between the Revogene GBS LB assay and the GeneXpert GBS LB assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, we report that both assays perform well for the detection of GBS colonization in pregnant women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-019-4756-y","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T06:02:49Z","timestamp":1578981769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative study of Revogene GBS LB assay and GeneXpert GBS LB assay for the detection of group B Streptococcus in prenatal screening samples"],"prefix":"10.1186","volume":"20","author":[{"given":"Tsokyi","family":"Choera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney","family":"Jung-Hynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"4756_CR1","unstructured":"Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC, Prevention. 2010. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:1\u201336. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21088663."},{"key":"4756_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3201\/eid1502.080842","volume":"15","author":"A Haleis","year":"2009","unstructured":"Haleis A, Alfa M, Gottschalk M, Bernard K, Ronald A, Manickam K. Meningitis caused by Streptococcus suis serotype 14, North America. Emerg Infect Dis. 2009;15:350\u20132.","journal-title":"Emerg Infect Dis"},{"key":"4756_CR3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinchem\/46.3.324","volume":"46","author":"D Ke","year":"2000","unstructured":"Ke D, Menard C, Picard FJ, Boissinot M, Ouellette M, Roy PH, Bergeron MG. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000;46:324\u201331.","journal-title":"Clin Chem"},{"key":"4756_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1586\/14737159.1.2.175","volume":"1","author":"D Ke","year":"2001","unstructured":"Ke D, Bergeron MG. Molecular methods for rapid detection of group B streptococci. Expert Rev Mol Diagn. 2001;1:175\u201381.","journal-title":"Expert Rev Mol Diagn"},{"key":"4756_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0140-6736(05)65391-3","volume":"348","author":"P Jakobi","year":"1996","unstructured":"Jakobi P, Goldstick O, Sujov P, Itskovitz-Eldor J. New CDC guidelines for prevention of perinatal group B streptococcal disease. Lancet. 1996;348:969.","journal-title":"Lancet"},{"key":"4756_CR6","first-page":"109","volume":"58","author":"CDC","year":"2009","unstructured":"CDC. Trends in perinatal group B streptococcal disease\u2014United States, 2000-2006. MMWR Morb Mortal Wkly Rep. 2009;58:109\u201312.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4756_CR7","doi-asserted-by":"crossref","unstructured":"Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ, Active Bacterial Core surveillance\/Emerging Infections Program N. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056\u20132065.","DOI":"10.1001\/jama.299.17.2056"},{"key":"4756_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1086\/424518","volume":"39","author":"HD Davies","year":"2004","unstructured":"Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis. 2004;39:1129\u201335.","journal-title":"Clin Infect Dis"},{"key":"4756_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0029-7844(96)00320-1","volume":"88","author":"MK Yancey","year":"1996","unstructured":"Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996;88:811\u20135.","journal-title":"Obstet Gynecol"},{"key":"4756_CR10","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1128\/JCM.01262-08","volume":"46","author":"T Block","year":"2008","unstructured":"Block T, Munson E, Culver A, Vaughan K, Hryciuk JE. Comparison of carrot broth- and selective Todd-Hewitt broth-enhanced PCR protocols for real-time detection of Streptococcus agalactiae in prenatal vaginal\/anorectal specimens. J Clin Microbiol. 2008;46:3615\u201320.","journal-title":"J Clin Microbiol"},{"key":"4756_CR11","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1128\/JCM.00858-08","volume":"46","author":"NS Montague","year":"2008","unstructured":"Montague NS, Cleary TJ, Martinez OV, Procop GW. Detection of group B streptococci in Lim broth by use of group B streptococcus peptide nucleic acid fluorescent in situ hybridization and selective and nonselective agars. J Clin Microbiol. 2008;46:3470\u20132.","journal-title":"J Clin Microbiol"},{"key":"4756_CR12","unstructured":"Revogene. GBS LB assay. Retrieved from: http:\/\/wwwgenepoc-diagnosticscom\/clinical-test\/."},{"key":"4756_CR13","unstructured":"Cepheid. Xpert GBS LB. Retrieved from: http:\/\/wwwcepheidcom\/us\/cepheid-solutions\/clinical-ivd-tests\/sexual-health\/xpert-gbs-lb."},{"key":"4756_CR14","doi-asserted-by":"crossref","unstructured":"Tickler IA, Tenover FC, Dewell S, Le VM, Blackman RN, Goering RV, et al. Streptococcus agalactiae Strains with Chromosomal Deletions Evade Detection with Molecular Methods. J Clin Microbiol. 2019;57(4):e02040-18. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30760532.","DOI":"10.1128\/JCM.02040-18"},{"key":"4756_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1439-0450.2002.00553.x","volume":"49","author":"AAAO Hassan","year":"2002","unstructured":"Hassan AAAO, L\u00e4mmler C, Huber-Schlenstedt R. Molecular characterization of phenotypically CAMP-negative Streptococcus agalactiae isolated from bovine mastitis. J Vet Med B Infect Dis Vet Public Health. 2002;49:257\u20139.","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"issue":"11","key":"4756_CR16","first-page":"12017","volume":"9","author":"VMR Savini","year":"2016","unstructured":"Savini VMR, Filippis R, D\u2019Incecco E, Imperi M, Pataracchia M, Alfarone G, Fusilli P, Coclite E, D\u2019Incecco C, Fazii P, Creti R. CAMP-negative group B Streptococcus went unrecognized with Cepheid GeneXpert but was detected by Liofilchem\u00ae chromatic StrepB. Int J Clin Exp Pathol. 2016;9(11):12017\u201320.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4756-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:13:29Z","timestamp":1610478809000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4756-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4756"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4756-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11661\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/553487","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11661\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11661\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11661\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11661\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Per the institutional policy of the University of Wisconsin-Madison, the need for IRB approval was waived. Informed consent was not required per institutional policy, because testing was performed on residual specimen during the course of routine hospital operations and quality improvement.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that this study was conducted in the absence of any potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}